BVS
Price
$6.77
Change
+$0.11 (+1.65%)
Updated
Jun 27 closing price
Capitalization
330.84M
45 days until earnings call
NUWE
Price
$0.24
Change
-$0.02 (-7.69%)
Updated
Jun 27 closing price
Capitalization
2.42M
Interact to see
Advertisement

BVS vs NUWE

Header iconBVS vs NUWE Comparison
Open Charts BVS vs NUWEBanner chart's image
Bioventus
Price$6.77
Change+$0.11 (+1.65%)
Volume$2.03M
Capitalization330.84M
Nuwellis
Price$0.24
Change-$0.02 (-7.69%)
Volume$2.48M
Capitalization2.42M
BVS vs NUWE Comparison Chart in %
Loading...
BVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BVS vs. NUWE commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVS is a StrongBuy and NUWE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (BVS: $6.77 vs. NUWE: $0.23)
Brand notoriety: BVS and NUWE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BVS: 333% vs. NUWE: 19%
Market capitalization -- BVS: $330.84M vs. NUWE: $2.42M
BVS [@Medical Specialties] is valued at $330.84M. NUWE’s [@Medical Specialties] market capitalization is $2.42M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVS’s FA Score shows that 0 FA rating(s) are green whileNUWE’s FA Score has 1 green FA rating(s).

  • BVS’s FA Score: 0 green, 5 red.
  • NUWE’s FA Score: 1 green, 4 red.
According to our system of comparison, NUWE is a better buy in the long-term than BVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVS’s TA Score shows that 3 TA indicator(s) are bullish while NUWE’s TA Score has 5 bullish TA indicator(s).

  • BVS’s TA Score: 3 bullish, 2 bearish.
  • NUWE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NUWE is a better buy in the short-term than BVS.

Price Growth

BVS (@Medical Specialties) experienced а +3.36% price change this week, while NUWE (@Medical Specialties) price change was -17.50% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +1.35%, and the average quarterly price growth was -0.23%.

Reported Earning Dates

BVS is expected to report earnings on Aug 12, 2025.

NUWE is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (+1.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BVS($331M) has a higher market cap than NUWE($2.42M). BVS has higher P/E ratio than NUWE: BVS (10.66) vs NUWE (0.02). BVS YTD gains are higher at: -35.524 vs. NUWE (-79.270). NUWE has higher annual earnings (EBITDA): -16.36M vs. BVS (-23.07M). BVS has more cash in the bank: 37M vs. NUWE (3.8M). NUWE has less debt than BVS: NUWE (760K) vs BVS (395M). BVS has higher revenues than NUWE: BVS (512M) vs NUWE (8.86M).
BVSNUWEBVS / NUWE
Capitalization331M2.42M13,689%
EBITDA-23.07M-16.36M141%
Gain YTD-35.524-79.27045%
P/E Ratio10.660.0257,950%
Revenue512M8.86M5,776%
Total Cash37M3.8M974%
Total Debt395M760K51,974%
FUNDAMENTALS RATINGS
NUWE: Fundamental Ratings
NUWE
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BVSNUWE
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PD15.230.33
+2.21%
PagerDuty
ALV113.101.97
+1.77%
Autoliv
SBFG18.370.29
+1.60%
SB Financial Group
TNFA0.13N/A
+1.20%
TNF Pharmaceuticals Inc.
DJCO419.020.52
+0.12%
Daily Journal Corp

BVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BVS has been loosely correlated with OFIX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BVS jumps, then OFIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVS
1D Price
Change %
BVS100%
+1.65%
OFIX - BVS
53%
Loosely correlated
+0.45%
TCMD - BVS
41%
Loosely correlated
+0.98%
RDNT - BVS
36%
Loosely correlated
-1.57%
CSTL - BVS
35%
Loosely correlated
+2.94%
MMSI - BVS
35%
Loosely correlated
+0.74%
More

NUWE and

Correlation & Price change

A.I.dvisor tells us that NUWE and CORBF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NUWE and CORBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUWE
1D Price
Change %
NUWE100%
-10.81%
CORBF - NUWE
24%
Poorly correlated
N/A
PRE - NUWE
24%
Poorly correlated
-6.11%
BNR - NUWE
23%
Poorly correlated
-9.97%
BVS - NUWE
22%
Poorly correlated
+1.65%
BLOZF - NUWE
22%
Poorly correlated
+1.64%
More